Corticosteroid use in the treatment of neuromuscular disorders: empirical and evidence-based data

Muscle & Nerve
Mark B Bromberg, Orly Carter

Abstract

Corticosteroids have been used to treat neuromuscular disorders for many years. With few randomized, controlled trials, efficacy has been established primarily from empirical data. This has led to a range of treatment regimens varying in terms of initial dosing, dosing schedules, and taper rates. The goals of this review were to examine the literature for data concerning corticosteroid pharmacokinetics and for evidence-based treatment regimens in several prototypic neuromuscular disorders. The results provide a number of sound principles for corticosteroid use, but also indicate that corticosteroid regimens and patient management are largely based on empirical clinical experiences.

References

Feb 1, 1975·Lancet·T L Munsat, J N Walton
Sep 1, 1975·Journal of the Neurological Sciences·D Riddoch, J A Morgan-Hughes
Jan 1, 1976·Medicine·L Axelrod
Feb 26, 1976·The New England Journal of Medicine·H O Conn, B L Blitzer
Mar 1, 1979·Clinical Pharmacokinetics·M E Pickup
Apr 1, 1979·British Journal of Clinical Pharmacology·A R TannerL W Powell
Jan 1, 1978·Clinical Pharmacology and Therapeutics·A AngeliF Ceresa
May 1, 1978·The American Journal of Medicine·A S Fauci
Mar 1, 1976·Annals of Internal Medicine·A S FauciJ E Balow
Apr 1, 1976·Journal of Pharmacokinetics and Biopharmaceutics·T J SullivanJ G Wagner
Nov 1, 1976·Archives of Neurology·R C Griggs, R Nash
Feb 13, 1975·The New England Journal of Medicine·A Bohan, J B Peter
Oct 1, 1975·The Journal of Clinical Endocrinology and Metabolism·A W MeikleF H Tyler
Dec 1, 1975·Brain : a Journal of Neurology·R DeVere, W G Bradley
Apr 1, 1976·Journal of the Neurological Sciences·J W Prineas, J G McLeod
May 28, 1992·The New England Journal of Medicine·H J Mankin
Aug 1, 1991·Neurology·E J Dropcho, S J Soong
Sep 1, 1991·The American Journal of Medicine·J L CarsonE Sim
Feb 11, 1991·Archives of Ophthalmology·M C LeskeS Y Wu
May 1, 1991·Annals of Internal Medicine·J M PiperM R Griffin
Aug 1, 1990·Clinical Pharmacokinetics·B M Frey, F J Frey
Jun 15, 1989·The New England Journal of Medicine·J R MendellJ Florence
Nov 1, 1989·Reviews of Infectious Diseases·A E StuckF J Frey
Jul 1, 1985·The Journal of Clinical Endocrinology and Metabolism·T H SchürmeyerG P Chrousos
Nov 1, 1987·Endocrine Reviews·F J Frey
Apr 1, 1988·Clinical Pharmacology and Therapeutics·A E StuckF J Frey
Jan 5, 1987·The Medical Journal of Australia·E J BeggN Gianarakis
Aug 1, 1987·Archives of Neurology·S DeSilvaR W Kuncl
Jan 1, 1985·Journal of Chronic Diseases·H O Conn, T Poynard
Oct 1, 1985·Acta Orthopaedica Scandinavica·H J MetselaarW Weimar
Jul 1, 1985·The Journal of Clinical Endocrinology and Metabolism·F F HorberF J Frey

❮ Previous
Next ❯

Citations

Sep 14, 2011·Current Treatment Options in Neurology·Hugh J McMillanPeter B Kang
Sep 24, 2009·Neurocritical Care·Logan M McDaneldAnish Bhardwaj
Jun 1, 2005·Journal of Clinical Neuromuscular Disease·Mark B Bromberg
Apr 9, 2009·International Journal of Rehabilitation Research. Internationale Zeitschrift Für Rehabilitationsforschung. Revue Internationale De Recherches De Réadaptation·Alberto Raggi, Matilde Leonardi
Sep 21, 2013·Neuroreport·Mei LiCaihui Gong
Mar 15, 2006·Expert Review of Neurotherapeutics·Masaaki Odaka
Apr 15, 2008·Expert Opinion on Biological Therapy·F Eftimov, I N van Schaik
Apr 29, 2010·Neuromuscular Disorders : NMD·J van de VlekkertUNKNOWN Dexa Myositis Trial
Jun 5, 2007·Journal of the Neurological Sciences·Agnes Jani-Acsadi, Robert P Lisak
Jan 14, 2017·The Cochrane Database of Systematic Reviews·Anne Louise OaklanderColin H Chalk
Nov 2, 2016·The Cochrane Database of Systematic Reviews·Richard Ac HughesPieter A van Doorn
Dec 1, 2017·The Cochrane Database of Systematic Reviews·Richard Ac HughesYusuf A Rajabally
Jan 7, 2015·The Cochrane Database of Systematic Reviews·Richard A C Hughes, Man Mohan Mehndiratta
Oct 31, 2020·European Journal of Hospital Pharmacy. Science and Practice·Eugenia PiscitelliFrancesco Habetswallner
Oct 27, 2020·Journal of Neuromuscular Diseases·Mattia QuattrocelliElizabeth M McNally

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Bertrand Godeau, Philippe Bierling
European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
J I O'RiordanR S Howard
© 2022 Meta ULC. All rights reserved